Dalbergia ecastaphyllum leaf extracts: in vitro inhibitory potential against enzymes related to metabolic syndrome, inflammation and neurodegenerative diseases



Document title: Dalbergia ecastaphyllum leaf extracts: in vitro inhibitory potential against enzymes related to metabolic syndrome, inflammation and neurodegenerative diseases
Journal: Acta scientiarum. Biological sciences
Database: PERIÓDICA
System number: 000433537
ISSN: 1679-9283
Authors: 1
2
3
3
2
3
4
Institutions: 1Universidade de Sao Paulo, Centro de Energia Nuclear na Agricultura, Piracicaba, Sao Paulo. Brasil
2Instituto Superior de Engenharia do Porto, Rede de Quimica e Tecnologia, Laboratorio Associado para a Quimica Verde, Porto. Portugal
3Universidade Federal do Reconcavo da Bahia, Centro de Ciencias Agrarias, Ambientais e Biologicas, Cruz das Almas, Bahia. Brasil
4Instituto Politecnico de Braganca, Centro de Investigacao de Montanha, Braganca. Portugal
Year:
Volumen: 41
Country: Brasil
Language: Inglés
Document type: Artículo
Approach: Analítico, descriptivo
English abstract For the first time, the anti-hemolytic activity and the enzyme inhibitory activities of Dalbergia ecastaphyllum leaves extracts were tested against α-amylase, α-glucosidase, lipase, acetylcholinesterase, butyrylcholinesterase, tyrosinase and hyaluronidase. The phenolic profile of the obtained extracts was also investigated by high-performance liquid chromatography with photodiode array detection (HPLC-PAD). The extracts showed inhibitory activity against all enzymes evaluated, with the highest inhibitory activity reported for the enzyme hyaluronidase (28.28 ± 2.43 to 72.19 ± 1.40 μg mL-1). The obtained extracts also demonstrate anti-hemolytic activity (52.22 ± 1.62 to 71.17 ± 1.82%). Among the phenolic compounds identified, protocatechuic, vanillic and β-resorcylic acids were the most abundant (1.13 ± 0.06 to 2.53 ± 0.06, 0.90 ± 0.06 to 2.19 ± 0.06 and 1.03 ± 1.62 to 22.11 ± 1.62 mg L-1, respectively). In the statistical analysis, a significant correlation was found between the flavonoids content and all enzymes inhibitory activities. The present study showed that D. ecastaphyllum leaves extracts may have the potential to be used in the therapeutic treatment of several diseases such as Alzheimer, Parkinson, type 2 diabetes mellitus, hyperglycemia, and pigmentation, as well as those associated with oxidative stress
Disciplines: Biología,
Química,
Medicina
Keyword: Angiospermas,
Fitoquímica,
Farmacología,
Extractos vegetales,
Ensayos clínicos,
Acetilcolinesterasa,
Alfa-glucosidasa,
Hialuronidasa,
Actividad enzimática,
Dalbergia ecastaphyllum,
Fabaceae
Keyword: Angiosperms,
Phytochemistry,
Pharmacology,
Plant extracts,
Clinical assays,
Acetylcholinesterase,
Alpha-glycosidase,
Hyaluronidase,
Enzymatic activity,
Dalbergia ecastaphyllum,
Fabaceae
Full text: http://periodicos.uem.br/ojs/index.php/ActaSciBiolSci/article/view/46622/751375148692